… coronary artery bypass grafting (CABG) and percutaneous … procedure of care for patients
undergoing revascularization. GP … , one of the major factors affecting the invivo performance of …

… Percutaneous coronary intervention (PCI) is the priority treatment for CAD patients because
it … Even though, CAD patients undergoing PCI might experience symptomatic complications …

… bypass grafting ( CABG ) for left main coronary artery disease with or … that most patients with
LMCA disease undergo CABG. … therapy (ie, high‐potency statins, newer P2Y12 inhibitors, …

… , ≈13% of patients who undergo CABG require repeat … Prasugrel and ticagrelor are
faster-acting and more potent … DAPT in patients with stable CAD after CABG but recommend …

… PCI, may be reasonable in patients undergoing coronary revascularization as part of the …
major clinical outcomes in patients with left main CAD were similar between CABG and PCI at 1…

… improve the management of ULMCAD patients undergoing CABG. Fibroblast growth
factor-23 (… Factors affecting the cumulative MACCE rate were determined using forward-stepwise …

… In this study, stable CAD was characterized by patients who had either undergone … to our
findings, having platelet stimulated with a more potent agonist or a combination of two agonists …

… in the number of patients with coronary artery disease (CAD) [1]… males who had undergone
coronary bypass surgery for grade … LA potency on the prognosis of coronary graft operation in …

… the risk of graft failure post coronary artery bypass graft surgery. … rapid onset of action and
potent platelet inhibition than clopidogrel. … We also aimed to compare the treatment regimens to …

… The relative role of coronary artery bypass grafting (CABG) … often achieved in patients who
underwent CABG rather than PCI, … of CABG and PCI with new-generation DESs, more potent …